or Try an Advanced Search...

    Small Cell Lung Cancer Stocks List

    Symbol Grade Name % Change
    SBFM F Sunshine Biopharma Inc. -1.18
    PSTV F Plus Therapeutics, Inc. 0.84
    EGRX F Eagle Pharmaceuticals, Inc. 6.25
    AGEN F Agenus Inc. 6.74
    CRIS F Curis, Inc. 9.73
    ADAP F Adaptimmune Therapeutics plc -3.64
    BCAB F BioAtla, Inc. -6.07
    BYSI F BeyondSpring, Inc. -2.34
    NXTC F NextCure, Inc. -1.48
    ACHV F Achieve Life Sciences, Inc. 0.81
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies
    Related Stock Lists: Cancer Clinical Medicine Non Small Cell Lung Cancer Biopharmaceutical Medicine Breast Cancer Cancer Treatment Drugs Lymphoma Melanoma Multiple Myeloma Oncolytics Biotech Ovarian Cancer Pharmaceutical Solid Tumors Treatment Of Breast Cancer Advanced Non Small Cell Lung Cancer Cancer Immunotherapy Carcinoma Docetaxel

    Related ETFs - A few ETFs which own one or more of the above listed Small Cell Lung Cancer stocks.

    Symbol Grade Name Weight
    SURI C Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 0.99
    FORH D Formidable ETF 0.79
    QQQS C Invesco NASDAQ Future Gen 200 ETF 0.3
    IWC B iShares Microcap ETF 0.09
    GWX D SPDR S&P International SmallCap ETF 0.02
    View all Small Cell Lung Cancer ETFs...
    Compare ETFs
    Compare FORH to GWX Compare SURI to GWX Compare SURI to QQQS

        Small Cell Lung Cancer Stocks Recent News

        Date Stock Title
        Nov 19 AGEN Agenus (AGEN) Loses -41.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
        Nov 19 NXTC Preclinical Data Demonstrates Anti-Siglec-15 Treatment Enhanced Generation of Quality Bone with Better Mechanical Properties in Mice with Moderate-to-Severe Osteogenesis Imperfecta
        Nov 18 AGEN Agenus (AGEN) Loses -41.13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
        Nov 17 PSTV Plus Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 16 PSTV Plus Therapeutics, Inc. (PSTV) Q3 2024 Earnings Call Transcript
        Nov 16 ADAP Adaptimmune Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 15 EGRX Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration
        Nov 15 AGEN Down -39.39% in 4 Weeks, Here's Why Agenus (AGEN) Looks Ripe for a Turnaround
        Nov 15 ADAP Halozyme bids for Evotec; BeiGene gets a new name
        Nov 15 PSTV Plus Therapeutics Inc (PSTV) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...
        Nov 14 PSTV Plus Therapeutics GAAP EPS of -$0.37 beats by $0.19, revenue of $1.45M beats by $0.31M
        Nov 14 PSTV Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies
        Related Stock Lists: Cancer Clinical Medicine Non Small Cell Lung Cancer Biopharmaceutical Medicine Breast Cancer Cancer Treatment Drugs Lymphoma Melanoma Multiple Myeloma Oncolytics Biotech Ovarian Cancer Pharmaceutical Solid Tumors Treatment Of Breast Cancer Advanced Non Small Cell Lung Cancer Cancer Immunotherapy Carcinoma Docetaxel
        Small Cell Lung Cancer

        Small cell lung cancer (SCLC) is a type of lung cancer that is characterized by the rapid growth of malignant cells in the lungs. It is an aggressive form of cancer that is usually found in the central part of the lungs. SCLC is often caused by smoking and is more common in men than women. Symptoms of SCLC include coughing, chest pain, shortness of breath, and weight loss. Treatment for SCLC typically involves chemotherapy and radiation therapy.

        Browse All Tags